Proteomics as a tool for assessment of therapeutics in transfusion medicine: evaluation of prothrombin complex concentrates

Abstract

Proteomic technologies allow the identification of potentially modified proteins in clotting factor concentrates, indicating that they could become a useful tool for transfusion medicine to assess the impact of processing on the integrity of blood-derived therapeutics.